Latest Industry Articles

Masimo to Present in 20th Annual Needham Healthcare Conference

Masimo to Present in 20th Annual Needham Healthcare Conference

 Masimo  (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at  www.masimo.co

Read more
Study Investigates the Effects of Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients

Study Investigates the Effects of Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients

Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 Masimo  (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impac

Read more
Study Investigates Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®

Study Investigates Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®

Masimo  (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the accuracy of plethysmographic respiration rate measurement (RRp®) using Masimo Rad-

Read more
Sri Lankan Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry

Sri Lankan Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry

Masimo  today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening strategy using Masimo

Read more
FDA Grants Emergency Use Authorization for New COVID-19, Flu A, Flu B Combo Kit

FDA Grants Emergency Use Authorization for New COVID-19, Flu A, Flu B Combo Kit

One multiplex real-time PCR diagnostic kit can simultaneously detect and differentiate SARS-CoV-2, influenza A and influenza B The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the  Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit &nb

Read more
Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately  $450 million  in cash. Under the terms of the agree

Read more
Fresenius Medical Care Expands Critical Care Offering With ExThera Medical’s Seraph 100 Adsorber

Fresenius Medical Care Expands Critical Care Offering With ExThera Medical’s Seraph 100 Adsorber

Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, will offer the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation in several European countries as of now. Both companies have signed a co-marketing and d

Read more
Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available

Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS ®  B•R•A•H•M•S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and othe

Read more
A new approach to AFib management

New ESC Guidelines for Atrial Fibrillation Published

The European Society of Cardiology ( ESC ) has published their new guidelines for the diagnosis and treatment of atrial fibrillation during its congress this year*. The recently released guidelines replace the recommendations of the Society, which were published in 2016. One of the most interes

Read more
Nova Biomedical logo

New Laboratory Blood Glucose Reference Analyzer from Nova Biomedical

Nova Biomedical announces the availability of Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer. Nova Primary fills the need for a new glucose reference analyzer to replace the YSI STAT PLUS 2300 Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH). Man

Read more

Highlighted Products